Showing results (351-360 of 518) with videos related to

Sort By:
Pageof 52
Pacing and Clinical Electrophysiology : PACE|October 3, 2009
Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patientsSandra B Dunbar, Jonathan J Langberg, Carolyn M Reilly, et al.
Pituitary|June 26, 2007
Glucocorticoid inhibition of growth in rats: partial reversal with the full-length ghrelin analog BIM-28125Giovanni Tulipano, John E Taylor, Heather A Halem, et al.
Genes|July 6, 2018
Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine CellsKristina B V Døssing, Christina Kjær, Jonas Vikeså, et al.
European Journal of Endocrinology|July 5, 2005
Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapyP Jaquet, G Gunz, A Saveanu, et al.
Journal of Endocrinological Investigation|April 22, 2006
BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotideP Jaquet, G Gunz, A Saveanu, et al.
The Journal of Invasive Cardiology|March 4, 2003
Practice and outcomes of percutaneous coronary intervention in the community before drug-eluting stents: a report from the HCA databaseDavid J Cohen, Frank Houser, Michael Mack, et al.
Nursing Outlook|November 12, 2013
A pilot test of an integrated self-care intervention for persons with heart failure and concomitant diabetesSandra B Dunbar, Brittany Butts, Carolyn M Reilly, et al.
The Journal of Knee Surgery|July 7, 2026
A Comparative Analysis of Lower Extremity Deformity Correction: Two-Dimensional vs. Three-Dimensional Computer TomographyAndrew Dobitsch, Ryan Palmer, Avinash Iyer, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomasA Saveanu, G Gunz, H Dufour, et al.
Peptides|January 1, 1983
In vitro pituitary hormone releasing activity of 40 residue human pancreatic tumor growth hormone releasing factorA Arimura, M D Culler, C M Turkelson, et al.
Pageof 52